Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Caraglia

Showing results (1-10 of 448) with videos related to

Pageof 45
Sort By:
Current Cancer Drug Targets|December 23, 2009
Target therapy of bone metastases and tumoursMichele Caraglia, Daniele Santini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer: Rapid Turnover and Use of Folates Alter its Study-LetterAlessandro Ottaiano, Michele Caraglia
Current Drug Metabolism|March 6, 2012
Nanotechnological and biotechnological strategies for drug deliveryMassimiliano Galdiero, Michele Caraglia
Frontiers in Oncology|October 11, 2021
Bevacizumab-Induced Tumor Vasculature Normalization and Sequential Chemotherapy in Colorectal Cancer: An Interesting and Still Open QuestionAlessandro Ottaiano, Michele Caraglia
Expert Review of Anticancer Therapy|February 24, 2011
The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?Raffaele Addeo, Michele Caraglia
Expert Opinion on Pharmacotherapy|May 2, 2009
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectivesStefano Fogli, Michele Caraglia
Expert Opinion on Investigational Drugs|May 3, 2011
Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Raffaele Addeo, Michele Caraglia
Molecular Therapy. Nucleic Acids|October 8, 2014
From Protein Synthesis to Molecular Biology: The Appealing Tale of eIF-5AMichele Caraglia, Concetta Alaia, Marina Porcelli
Expert Opinion on Biological Therapy|June 14, 2008
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, ItalyMichele Caraglia, Monica Marra, Alfredo Budillon
Expert Opinion on Biological Therapy|May 15, 2008
Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, ItalyMichele Caraglia, Monica Marra, Alfredo Budillon
Pageof 45

Showing results (1-10 of 448) with videos related to

Sort By:
Pageof 45
Current Cancer Drug Targets|December 23, 2009
Target therapy of bone metastases and tumoursMichele Caraglia, Daniele Santini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer: Rapid Turnover and Use of Folates Alter its Study-LetterAlessandro Ottaiano, Michele Caraglia
Current Drug Metabolism|March 6, 2012
Nanotechnological and biotechnological strategies for drug deliveryMassimiliano Galdiero, Michele Caraglia
Frontiers in Oncology|October 11, 2021
Bevacizumab-Induced Tumor Vasculature Normalization and Sequential Chemotherapy in Colorectal Cancer: An Interesting and Still Open QuestionAlessandro Ottaiano, Michele Caraglia
Expert Review of Anticancer Therapy|February 24, 2011
The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?Raffaele Addeo, Michele Caraglia
Expert Opinion on Pharmacotherapy|May 2, 2009
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectivesStefano Fogli, Michele Caraglia
Expert Opinion on Investigational Drugs|May 3, 2011
Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Raffaele Addeo, Michele Caraglia
Molecular Therapy. Nucleic Acids|October 8, 2014
From Protein Synthesis to Molecular Biology: The Appealing Tale of eIF-5AMichele Caraglia, Concetta Alaia, Marina Porcelli
Expert Opinion on Biological Therapy|June 14, 2008
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, ItalyMichele Caraglia, Monica Marra, Alfredo Budillon
Expert Opinion on Biological Therapy|May 15, 2008
Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, ItalyMichele Caraglia, Monica Marra, Alfredo Budillon
Pageof 45